In 1998 was created Hepalink, which is appeared as Corporate Investor. The venture was found in Asia in China. The leading representative office of defined Corporate Investor is situated in the Shenzhen.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Hepalink, startups are often financed by Wellcome Trust, TVM Capital, TPG Biotech. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Wellcome Trust, TVM Capital. In the next rounds fund is usually obtained by Xeraya Capital, Bill & Melinda Gates Foundation, Bain Capital Life Sciences.
Considering the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2015.
The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Rapid Micro Biosystems, OncoQuest. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada.
Related Funds
Fund Name | Location |
Accelerator Fund | Pennsylvania, Pittsburgh, United States |
Ascletis | Chapel Hill, North Carolina, United States |
Boldcap Ventures | New York, New York, United States |
Bsquare | Bellevue, United States, Washington |
Chinese Consortium | China, Jiangsu, Suzhou |
CNN | Atlanta, Georgia, United States |
Emerald Development Managers | New York, New York, United States |
FastForward | Area A, Palestinian Territory, West Bank |
Franklin Capital Corporation | Salt Lake City, United States, Utah |
Fuli Capital | China, Futian, Guangdong |
Guangzhou Lianka Yueyuan Fazhan Youxian Gongsi | China, Guangdong Province, Huangpu District |
H2 Investment Properties | California, San Francisco, United States |
Infcurion Group | Chiyoda, Japan |
Locojoy | Beijing, Beijing, China |
Lowe's Innovation Labs | Bengaluru, India, Karnataka |
Nex Cubed Digital Health | California, San Diego, United States |
OneLiberty Ventures | Cambridge, Massachusetts, United States |
Prime Block Capital | - |
The March Fund | China, Hong Kong, Hong Kong Island |
Weimob | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Kymab | $100M | 24 Nov 2016 | England | ||
Rapid Micro Biosystems | $25M | 29 Apr 2015 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Kymab | $100M | 24 Nov 2016 | England | ||
Rapid Micro Biosystems | $25M | 29 Apr 2015 | Massachusetts, United States |